Zobrazeno 1 - 10
of 397
pro vyhledávání: '"F Zingone"'
Publikováno v:
Reumatismo, Vol 76, Iss 3 (2024)
Objective. Ulcerative colitis and Crohn’s disease are chronic inflammatory diseases and represent the two most important types of inflammatory bowel diseases (IBD), while spondyloarthritis (SpA) comprises a heterogeneous group of systemic inflammat
Externí odkaz:
https://doaj.org/article/75f5953c304f4ca4801b08b69a9210b6
Autor:
A. Costa, N.W. Sneddon, A. Goi, G. Visentin, L.M.E. Mammi, E.V. Savarino, F. Zingone, A. Formigoni, M. Penasa, M. De Marchi
Publikováno v:
Journal of Dairy Science, Vol 106, Iss 8, Pp 5197-5217 (2023)
ABSTRACT: Mammalian colostrum, known as “liquid gold,” is considered a valuable source of essential nutrients, growth factors, probiotics, prebiotics, antibodies, and other bioactive compounds. Precisely for this reason, bovine colostrum (BC) is
Externí odkaz:
https://doaj.org/article/45d3a04f5f184546b4126106120500ad
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Gastroenterology Research and Practice, Vol 2018 (2018)
Background. Patients with inflammatory bowel diseases could experience mouth and teeth disorders and alterations in psychological mood. Vice versa, the psychological status may influence the presence of oral diseases. Aim. To evaluate in inflammatory
Externí odkaz:
https://doaj.org/article/0079d967344f487d8de263b1558650f8
Autor:
M.A. Latorre, P. Bianchi, M. Lenti, N. Aronico, C. Petrucci, C. D'Agate, M. Neri, U. Volta, M. Mumolo, M. Astegiano, A. Calabro, F. Zingone, G. Latella, A. Di Sario, A. Carroccio, C. Ciacci, F. Luzza, C. Bagnato, M. Fantini, L. Elli, G. Cammarota, A. Gasbarrini, P. Portincasa, C. Quatraccioni, C. Iannelli, N. Vecchione, G. Broglio, G. Ianiro, I. Marsilio, S. Bibbo, B. Marinoni, D. Tomaselli, L. Abenavoli, R. Pilia, G. Santacroce, E. Lynch, A. Carrieri, P. Mansueto, M. Gabba, G. Alunno, C. Rossi, F. Onnis, K. Efthymakis, N. Cesaro, M. Vernero, F. Baiano Svizzero, M. Silano, C. Klersy, G. Corazza, A. Di Sabatino
Publikováno v:
Digestive and Liver Disease. 55:S158-S159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc776694377b8739dc2343f8c21431af
https://doi.org/10.1016/s1590-8658(23)00388-2
https://doi.org/10.1016/s1590-8658(23)00388-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M De Ruvo, B Barberio, F Zingone, L Bonanno, A Dal Maso, F Stefano, V Chiarion Sileni, E V Savarino
Publikováno v:
Journal of Crohn's and Colitis. 17:i695-i696
Background Anti-programmed death-1 (PD-1) drugs have been associated with immune-mediated gastrointestinal adverse events in 0.5-9% of the cases. The aim of this study was to investigate the characteristics of colitis occurring in oncological patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::216fd03403bd34e266d31bb154424912
https://doi.org/10.1093/ecco-jcc/jjac190.0696
https://doi.org/10.1093/ecco-jcc/jjac190.0696
Autor:
D G Ribaldone, S Vieujean, M Julsgaard, F Zingone, E Savarino, F Cañete, A Aratari, N Imperatore, L Ramos, R Plaza, D Pugliese, B Barberio, D Drobne, M Chaparro
Publikováno v:
Journal of Crohn's and Colitis. 17:i403-i404
Background There are limited data available on the course of IBD in patients with solid organ transplantation. The aim of this ECCO CONFER study was to evaluate the trend of IBD before and after solid organ transplantation but liver. Methods This was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ec470a249568ad1a03fc3455763d7df
https://doi.org/10.1093/ecco-jcc/jjac190.0382
https://doi.org/10.1093/ecco-jcc/jjac190.0382
Autor:
L Cingolani, B Barberio, A Zelante, D Ribaldone, G Testa, L Bertani, A Buda, F Zingone, E V Savarino
Publikováno v:
Journal of Crohn's and Colitis. 17:i668-i669
Background Tofacitinib is a small oral molecule approved to treat moderate to severe ulcerative colitis (UC), which effectiveness and safety is still poorly known in UC patients. Recent concerns have been raised regarding its administration at high d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa3e8d30db492c3ac1c7b5f31247969d
https://doi.org/10.1093/ecco-jcc/jjac190.0672
https://doi.org/10.1093/ecco-jcc/jjac190.0672
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.